LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

LLY

1,009.16

-0.69%↓

JNJ

230.44

+0.55%↑

ABBV

212.88

-0.06%↓

UNH

382.34

-2.4%↓

AZN

188.1

+1.47%↑

Home・Lista de Ações・Twist Bioscience Corp

Twist Bioscience Corp

Abrir

SetorSaúde

51.41 3.75

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

48.16

Máximo

51.46

Indicadores-chave
By Trading Economics
Rendimento	-14M -44M
Vendas	7M 111M
EPS	-0.597
Margem de lucro	-39.761
Funcionários	979
EBITDA	-16M -40M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+28.14% upside

Dividendos
By Dow Jones
Próximos Ganhos	3 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-345M 3.1B
Abertura anterior	47.66
Fecho anterior	51.41

Sentimento de Notícias

By Acuity

38%

62%

112 / 345 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Very Strong Bearish Evidence

31.56 / 38.6884 Suporte e Resistência

Twist Bioscience Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de mai. de 2026, 20:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Buy Empower Semiconductor for $1.5 Billion

19 de mai. de 2026, 23:47 UTC

Conversa de Mercado

Nikkei May Decline as Concerns About Energy, Material Costs Persists -- Market Talk

19 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

19 de mai. de 2026, 23:28 UTC

Conversa de Mercado

Ganhos

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 23:28 UTC

Conversa de Mercado

Ganhos

F&P Healthcare's Outlook Key for Investors -- Market Talk

19 de mai. de 2026, 23:10 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

19 de mai. de 2026, 23:10 UTC

Conversa de Mercado

Kiwi Property's Dividend Growth Reliant on Several Factors -- Market Talk

19 de mai. de 2026, 22:02 UTC

Ganhos

ZTO Express (Cayman): Di Xu to Resign From Board

19 de mai. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 1Q Adj EPS 43c >ZTO

19 de mai. de 2026, 22:01 UTC

Ganhos

ZTO Express (Cayman) 1Q EPS 39c >ZTO

19 de mai. de 2026, 22:00 UTC

Ganhos

ZTO Express (Cayman) 1Q Rev $1.93B >ZTO

19 de mai. de 2026, 21:37 UTC

Ganhos

Cracks Are Starting to Appear in the Chip Stock Rally -- Barrons.com

19 de mai. de 2026, 21:31 UTC

Aquisições, Fusões, Aquisições de Empresas

How NextEra Can Fix Dominion's Strange AI Problem -- Barrons.com

19 de mai. de 2026, 21:01 UTC

Ganhos

Home Depot Beats Earnings Estimates as Shoppers Defy Inflation Fears. The Stock Advances. -- Barrons.com

19 de mai. de 2026, 20:58 UTC

Ganhos

These Stocks Are Today's Movers: CoreWeave, Nvidia, Home Depot, Akamai, Agilysys, Micron, and More -- Barrons.com

19 de mai. de 2026, 20:46 UTC

Ações em Alta

Stocks to Watch Recap: ServiceNow, Home Depot, CoreWeave -- WSJ

19 de mai. de 2026, 20:43 UTC

Conversa de Mercado

Canada 30-Year Yield Hits Highest Level Since 2010 -- Market Talk

19 de mai. de 2026, 20:34 UTC

Ganhos

James Hardie Industries Sees FY27 Sales $5.25B-$5.41B >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries: Targeting Pro Forma Adjusted EBITDA Growth of 4% to 8% in FY27 >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries 4Q EPS 5c >JHX

19 de mai. de 2026, 20:32 UTC

Ganhos

James Hardie Industries 4Q Sales $1.4B >JHX

19 de mai. de 2026, 20:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Buy Empower Semiconductor for $1.5B

19 de mai. de 2026, 20:18 UTC

Conversa de Mercado

Canada CPI Data Has Accounting Quirk Related to Travel Tours -- Market Talk

19 de mai. de 2026, 20:13 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

19 de mai. de 2026, 20:13 UTC

Conversa de Mercado

'Hard to Square' Canada Rate Hikes Expectations Given Mild Core -- Market Talk

19 de mai. de 2026, 20:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices: Deal Further Advances Position as Strategic, System-Level Grid-To-Core Power Partner for Hyperscalers, AI Silicon Developers >ADI

19 de mai. de 2026, 20:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices: Phillips Will Continue Leading IVR Technology Efforts as Part of ADI >ADI

19 de mai. de 2026, 20:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices Will Acquire Empower in All-Cash Transaction for $1.5 B >ADI

19 de mai. de 2026, 20:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Analog Devices to Acquire Empower Semiconductor, Expanding Its Next-Generation High-Density Power Portfolio for the AI Era

19 de mai. de 2026, 19:23 UTC

Conversa de Mercado

Oil Futures Slip With Market Back on U.S.-Iran Deal Watch -- Market Talk

Comparação entre Pares

Variação de preço

Twist Bioscience Corp Previsão

Preço-alvo

By TipRanks

28.14% parte superior

Previsão para 12 meses

Média 63.43 USD 28.14%

Máximo 70 USD

Mínimo 56 USD

Com base em 7 analistas de Wall Street que oferecem metas de preço de 12 meses para Twist Bioscience Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

7 ratings

Comprar

Manter

Vender

Com base em 7 analistas que deram avaliações de ações para Twist Bioscience Corp - Dist nos últimos 3 meses.

Pontuação Técnica

By Trading Central

31.56 / 38.6884Suporte e Resistência

Recent bearish events outweigh bullish events.

Bearish events outweigh bullish events.

Sentimento

By Acuity

112 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.